Alzheimer’s Disease and Dementias: Insights for Early Detection and Care Planning _ ___________________
DOCUMENTATION Proper documentation is crucial for billing cognitive assess- ments accurately. It is also important to note that the total time spent on the assessment and care planning must meet the minimum requirements for the chosen billing code (typically 50 minutes for CPT code 99483). When using CPT Code 99483, healthcare providers should conduct a detailed assess- ment and document the assessment findings to include test scores and interpretations, clinical observations, and patient and caregiver reports. The detailed assessment should include: • Cognitive assessment using standardized tools (e.g., MMSE, Montreal Cognitive Assessment): Detailed evaluation of the patient’s cognitive function, including memory, attention, language, and executive function • Functional assessment: Evaluation of the patient’s ability to perform activities of daily living (ADLs) and instrumental activities of daily living (IADLs) • Medication review: Comprehensive review of all medi- cations the patient is taking, including prescription drugs, over-the-counter medications, and supplements • Safety evaluation: Assessment of the patient’s safety, including risks of falls, wandering, and other hazards • Caregiver assessment: Evaluation of the caregiver’s needs and the impact of caregiving on their health and well-being CARE PLANNING Care planning is essential in managing Alzheimer disease and other dementias, addressing multiple aspects of the patient’s health and well-being. A comprehensive care plan should out- line treatment goals, medication management strategies, safety measures (e.g., fall prevention), and methods to manage behav- ioral symptoms. It should also include cognitive stimulation activities, social engagement recommendations, and caregiver support and education. Early advance care planning discus- sions are crucial to ensure the patient’s wishes are respected as the disease progresses. Referrals to specialists and community resources should be included for comprehensive support. Person-centered care is vital, involving both the patient and caregivers in the planning process [22]. Healthcare providers should use clear language when explaining assessments and treatment options, encouraging patients to express their prefer- ences and concerns. Caregivers should be included in discussions about care goals and management strategies, as they often play a primary role in day-to-day care. Education about the disease process, expected progression, and available resources should be provided to both patients and caregivers. The needs of the family evolve as Alzheimer disease progresses, and this should be considered at all phases of patient care ( Table 6 ). The importance of advance directives should be discussed, and their completion encour- aged. Regular reviews and updates of the care plan, with input from both the patient and caregiver, ensure its relevance and effectiveness as the disease progresses. Throughout the process, healthcare providers should offer opportunities for patients and caregivers to ask questions and voice concerns, fostering a collaborative approach to care management.
COMMUNICATION TECHNIQUES Effective communication is crucial when caring for patients who have Alzheimer disease or other dementias. Healthcare providers should use clear, simple language, speak slowly, and maintain eye contact when discussing memory concerns. It is important to approach the topic sensitively, acknowledging the patient’s feelings and concerns [24]. Building trust and rapport involves active listening, showing empathy, and respecting the patient’s dignity. Providers should create a comfortable environment and allow ample time for the patient to process information and respond [22]. Engaging caregivers is equally important. Strategies include educating them about the disease, its progression, and avail- able resources. Caregivers should be encouraged to participate in appointments and care planning discussions. Addressing caregiver concerns involves providing emotional support, offer- ing respite care information, and connecting them with sup- port groups. Healthcare providers should also assess caregiver stress and burnout, offering strategies for self-care and stress management [25]. By fostering open communication with both patients and caregivers, providers can ensure more com- prehensive and effective care for individuals with dementia. TREATMENT OPTIONS Pharmacological treatments for dementia focus on managing symptoms and slowing disease progression. The main medi- cations include cholinesterase inhibitors (donepezil, rivastig- mine, galantamine) and an N -methyl-D-aspartate (NMDA) receptor antagonist, memantine. Cholinesterase inhibitors increase acetylcholine levels, improving cognitive function and behavioral symptoms in mild-to-moderate Alzheimer dis- ease [2]. Memantine regulates glutamate activity and is used for moderate to severe Alzheimer disease. These medications can improve cognition, mood, and daily functioning but may have side effects. Cholinesterase inhibitors can cause nausea, vomiting, diarrhea, dizziness, and sleep disturbances, while memantine may cause dizziness, headaches, and constipation [10]. Although they do not cure dementia, they can temporarily improve symptoms or slow their worsening [26]. The European Academy of Neurology suggests that the use of a combination of cholinesterase inhibitor (ChEI) plus memantine rather than ChEI alone may provide useful benefits in patients with moderate-to-severe Alzheimer disease. (https://onlinelibrary.wiley.com/doi/full/10.1111/ ene.12707. Last accessed August 21, 2024.) Level of Evidence : Expert Opinion/Consensus Statement
10
EliteLearning.com/Nursing
Book Code: ANCCTX2027
Powered by FlippingBook